NuVasive is reducing executive and board member compensation and taking other temporary cost-cutting measures during the COVID-19 pandemic, which has significantly lowered elective procedure volumes.
Author: Staff
Financial relief provided under the Coronavirus Aid, Relief and Economic Security Act won't be enough to keep musculoskeletal care providers afloat after the COVID-19 crisis, the American Association of Orthopaedic Surgeons said in an April 10 letter to congressional leaders.
Johnson & Johnson subsidiary Ethicon is scrapping plans to buy Takeda Pharmaceutical's TachoSil surgical patch for controlling bleeding, Reuters reports.
Axis Spine received $1 million (830,000 pounds) from three investors as it readies to advance its anterior spinal implant technology in the U.S., Business Leader reports.
Johnson & Johnson reported a 7.5 percent drop in orthopedic sales during the first quarter of 2020, disrupted by the coronavirus.
Advertisement
As the Ohio Economic Recovery Task Force examines ways to reopen businesses amid the COVID-19 pandemic, orthopedic surgeons are pushing for elective surgery and physical therapy to start up again, according to a Fox 28 report.
Medicrea reported its full-year 2019 and first-quarter 2020 financial results, posting a $17 million (15.6 million euro) loss on the year.
Google now allows physicians to enter a "virtual care offering" option into their business profiles so users searching for certain types of care can sign up for telehealth options directly.
A Barclays analyst cut her rating on Stryker amid the COVID-19 pandemic.
Across the nation, non-essential businesses have closed or transitioned to remote work while hospitals and surgical centers have canceled elective procedures to avoid further spreading the coronavirus and devote resources to treating COVID-19 patients.